Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors
This randomized clinical trial studies a cognitive-behavioral intervention to treat worry, uncertainty, and insomnia in cancer survivors. Counseling may reduce anxiety and insomnia as well as improve the well-being and quality of life of cancer survivors. This study also explores the neuro-immunologic correlates of anxiety and insomnia.
Checked against the public recordLast updated Apr 5, 2017 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Interventions being studied
- Behavioral: Cognitive-behavioral therapy for worry, uncertainty & insomnia
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * lung cancer * stage III or IV colorectal cancer * pancreatic cancer * esophageal cancer * multiple myeloma * leukemia * stage IIIC and IV melanoma * ovarian cancer * stage III \& IV cervical cancer * stage III \& IV uterine cancer * stage IIIB, IIIC, and IV breast cancer * glioblastoma multiforme * early relapse (\< 1 year) lymphoma Exclusion Criteria: * co-morbid immunologic disease (i.e. rheumatoid arthritis, systemic lupus) * neurologic disease (i.e. multiple sclerosis, Parkinson's, Alzheimer's) that would affect neuro-immune assessment or completion of study questionnaires * mania (if patient has bipolar disorder) * active substance abuse disorders such as alcohol dependence and cocaine abuse will also be excluded
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Wexner Medical Center at The Ohio State University Department of PsychiatryColumbus, Ohio
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 5, 2017. Always confirm current availability with the study team.